Actas Dermo-Sifiliográficas

RF ¿ Tildrakizumab 200mg. Is Double Dosing Really a Window of Opportunity? C. Llamas-Segura; M. Cebolla-Verdugo; R. Ruiz-Villaverde;

Tralokinumab Effectiveness in Moderate-to-severe Atopic Dermatitis With Palmoplantar Eczema J.J. Domínguez-Cruz; F.J. Navarro-Triviño; M. Galán-Gutiérrez; J.J. Pereyra-Rodríguez; J.C. Armario-Hita; R. Ruiz-Villaverde;

Multidisciplinary Delphi consensus between primary care and dermatology on updated management of actinic keratosis in spain L. Ferrándiz; J.A. Heras-Hitos; P. Casas Rodríguez; A. Valcarce-Leonisio; O. San Martín; R. Ruiz-Villaverde;